Neoadjuvant Immunotherapy Combined With Chemotherapy Leads to Pathological Complete Responses in a Rare Del Mutation Advanced Colon Cancer With Lynch Syndrome

LAI Xiao-rong; DONG Qiu-mei; MA Dong

doi:10.12019/j.issn.1671-5144.2020.05.013

LAI Xiao-rong, DONG Qiu-mei, MA Dong. Neoadjuvant Immunotherapy Combined With Chemotherapy Leads to Pathological Complete Responses in a Rare Del Mutation Advanced Colon Cancer With Lynch Syndrome[J]. Journal of Evidence-Based Medicine, 2020, 20(5): 316-320. DOI: 10.12019/j.issn.1671-5144.2020.05.013

Citation:

LAI Xiao-rong, DONG Qiu-mei, MA Dong. Neoadjuvant Immunotherapy Combined With Chemotherapy Leads to Pathological Complete Responses in a Rare Del Mutation Advanced Colon Cancer With Lynch Syndrome[J]. Journal of Evidence-Based Medicine, 2020, 20(5): 316-320. DOI: 10.12019/j.issn.1671-5144.2020.05.013

Citation:

LAI Xiao-rong, DONG Qiu-mei, MA Dong. Neoadjuvant Immunotherapy Combined With Chemotherapy Leads to Pathological Complete Responses in a Rare Del Mutation Advanced Colon Cancer With Lynch Syndrome[J]. Journal of Evidence-Based Medicine, 2020, 20(5): 316-320. DOI: 10.12019/j.issn.1671-5144.2020.05.013

Neoadjuvant Immunotherapy Combined With Chemotherapy Leads to Pathological Complete Responses in a Rare Del Mutation Advanced Colon Cancer With Lynch Syndrome

Graphical Abstract

Abstract

FullText(HTML)

References (10)

Neoadjuvant Immunotherapy Combined With Chemotherapy Leads to Pathological Complete Responses in a Rare Del Mutation Advanced Colon Cancer With Lynch Syndrome

Catalog

Export File

Citation

Format

Content